{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:24:09Z","timestamp":1794007449119,"version":"4.8.0"},"reference-count":45,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T00:00:00Z","timestamp":1750636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2021-12374386 e Ricerca Corrente"],"award-info":[{"award-number":["RF2021-12374386 e Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003196","name":"Ministero della Salute","doi-asserted-by":"publisher","award":["RF2021-12374386 e Ricerca Corrente"],"award-info":[{"award-number":["RF2021-12374386 e Ricerca Corrente"]}],"id":[{"id":"10.13039\/501100003196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","award":["U24 NS072026"],"award-info":[{"award-number":["U24 NS072026"]}],"id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","award":["P30 AG019610 and P30AG072980"],"award-info":[{"award-number":["P30 AG019610 and P30AG072980"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["MNESYS (PE0000006)"],"award-info":[{"award-number":["MNESYS (PE0000006)"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Neuropathol"],"DOI":"10.1007\/s00401-025-02904-4","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:43:47Z","timestamp":1750661027000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Quantification of Lewy body pathology by cerebrospinal fluid endpoint dilution RT-QuIC in a neuropathological autopsy cohort of clinically heterogeneous participants"],"prefix":"10.1007","volume":"149","author":[{"given":"Andrea","family":"Mastrangelo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Caldera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie E.","family":"Mastenbroek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Vittoriosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shorena","family":"Janelidze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geidy E.","family":"Serrano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Atri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Shill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Driver-Dunckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyamal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles H.","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Mammana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Magliocchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Baiardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Beach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero","family":"Parchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,23]]},"reference":[{"issue":"4","key":"2904_CR1","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1002\/ana.26453","volume":"92","author":"MR Arnold","year":"2022","unstructured":"Arnold MR, Coughlin DG, Brumbach BH, Smirnov DS, Concha-Marambio L, Farris CM et al (2022) \u03b1-synuclein seed amplification in csf and brain from patients with different brain distributions of pathological \u03b1-synuclein in the context of co-pathology and Non-LBD diagnoses. Ann Neurol 92(4):650\u2013662. https:\/\/doi.org\/10.1002\/ana.26453","journal-title":"Ann Neurol"},{"issue":"2","key":"2904_CR2","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00401-020-02255-2","volume":"141","author":"J Attems","year":"2021","unstructured":"Attems J, Toledo JB, Walker L, Gelpi E, Gentleman S, Halliday G et al (2021) Neuropathological consensus criteria for the evaluation of Lewy pathology in post-mortem brains: a multi-centre study. Acta Neuropathol 141(2):159\u2013172. https:\/\/doi.org\/10.1007\/s00401-020-02255-2","journal-title":"Acta Neuropathol"},{"issue":"6","key":"2904_CR3","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1007\/s00401-009-0538-8","volume":"117","author":"TG Beach","year":"2009","unstructured":"Beach TG, Adler CH, Lue L-F, Sue LI, Bachalakuri J, Henry-Watson J et al (2009) Unified staging system for Lewy body disorders: correlation with nigrostriatal degeneration, cognitive impairment and motor dysfunction. Acta Neuropathol 117(6):613\u2013634. https:\/\/doi.org\/10.1007\/s00401-009-0538-8","journal-title":"Acta Neuropathol"},{"issue":"4","key":"2904_CR4","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1111\/neup.12189","volume":"35","author":"TG Beach","year":"2015","unstructured":"Beach TG, Adler CH, Sue LI, Serrano G, Shill HA, Walker DG et al (2015) Arizona study of aging and neurodegenerative disorders and brain and body donation program. Neuropathology 35(4):354\u2013389. https:\/\/doi.org\/10.1111\/neup.12189","journal-title":"Neuropathology"},{"issue":"4","key":"2904_CR5","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0231720","volume":"15","author":"TG Beach","year":"2020","unstructured":"Beach TG, Adler CH, Zhang N, Serrano GE, Sue LI, Driver-Dunckley E et al (2020) Severe hyposmia distinguishes neuropathologically confirmed dementia with Lewy bodies from Alzheimer\u2019s disease dementia. PLoS ONE 15(4):e0231720. https:\/\/doi.org\/10.1371\/journal.pone.0231720","journal-title":"PLoS ONE"},{"issue":"1","key":"2904_CR6","doi-asserted-by":"publisher","first-page":"389","DOI":"10.3233\/JAD-201213","volume":"79","author":"TG Beach","year":"2021","unstructured":"Beach TG, Malek-Ahmandi M (2021) Alzheimer\u2019s disease neuropathological comorbidities are common in the younger-Old. J Alzheimers Dis 79(1):389\u2013400. https:\/\/doi.org\/10.3233\/JAD-201213","journal-title":"J Alzheimers Dis"},{"key":"2904_CR7","doi-asserted-by":"publisher","DOI":"10.1101\/2025.01.13.25319971","author":"TH Beach","year":"2025","unstructured":"Beach TH, Serrano GE, Driver-Dunckley ED, Sue LI, Shill HA, Mehta SH et al (2025) Parkinson disease neuropathological comorbidities: prevalences from younger-old to older-old, with comparison to non-demented. Non-Parkinsonian Subjects medRxiv (preprint). https:\/\/doi.org\/10.1101\/2025.01.13.25319971","journal-title":"Non-Parkinsonian Subjects medRxiv (preprint)"},{"issue":"1","key":"2904_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s00401-023-02663-0","volume":"147","author":"GM Bentivenga","year":"2024","unstructured":"Bentivenga GM, Mammana A, Baiardi S, Rossi M, Ticca A, Magliocchetti F et al (2024) Performance of a seed amplification assay for misfolded alpha-synuclein in cerebrospinal fluid and brain tissue in relation to Lewy body disease stage and pathology burden. Acta Neuropathol 147(1):18. https:\/\/doi.org\/10.1007\/s00401-023-02663-0","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2904_CR9","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s00401-025-02853-y","volume":"149","author":"AM Bernhardt","year":"2025","unstructured":"Bernhardt AM, Longen S, Trossbach SV, Rossi M, Weckbecker D, Schmidt F et al (2025) A quantitative Lewy-fold-specific alpha-synuclein seed amplification assay as a progression marker for Parkinson\u2019s disease. Acta Neuropathol 149(1):20. https:\/\/doi.org\/10.1007\/s00401-025-02853-y","journal-title":"Acta Neuropathol"},{"issue":"1","key":"2904_CR10","doi-asserted-by":"publisher","first-page":"162","DOI":"10.1186\/s40478-023-01653-3","volume":"11","author":"S Br\u00e4uer","year":"2023","unstructured":"Br\u00e4uer S, Rossi M, Sajapin J, Henle T, Gasser T, Parchi P et al (2023) Kinetic parameters of alpha-synuclein seed amplification assay correlate with cognitive impairment in patients with Lewy body disorders. Acta Neuropathol Commun 11(1):162. https:\/\/doi.org\/10.1186\/s40478-023-01653-3","journal-title":"Acta Neuropathol Commun"},{"key":"2904_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-023-00627-5","author":"K Brockmann","year":"2024","unstructured":"Brockmann K, Lerche S, Baiardi S, Rossi M, Wurster I, Quadalti C et al (2024) CSF \u03b1-synuclein seed amplification kinetic profiles are associated with cognitive decline in Parkinson\u2019s disease. Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-023-00627-5","journal-title":"Parkinsons Dis"},{"issue":"Pt 5","key":"2904_CR12","doi-asserted-by":"publisher","first-page":"1493","DOI":"10.1093\/brain\/awr031","volume":"134","author":"Y Compta","year":"2011","unstructured":"Compta Y, Parkkinen L, O\u2019Sullivan S, Vandrovcova J, Holton JL, Collins C et al (2011) Lewy- and Alzheimer-type pathologies in Parkinson\u2019s disease dementia: which is more important? Brain 134(Pt 5):1493\u20131505. https:\/\/doi.org\/10.1093\/brain\/awr031","journal-title":"Brain"},{"issue":"1","key":"2904_CR13","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1002\/mds.27867","volume":"35","author":"DG Coughlin","year":"2020","unstructured":"Coughlin DG, Hurtig HI, Irwin DJ (2020) Pathological influences on clinical heterogeneity in lewy body diseases. Mov Disord 35(1):5\u201319. https:\/\/doi.org\/10.1002\/mds.27867","journal-title":"Mov Disord"},{"key":"2904_CR14","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.0000000000210279","author":"DG Coughlin","year":"2025","unstructured":"Coughlin DG, Shifflett B, Farris CM, Ma Y, Galasko D, Edland SD et al (2025) \u03b1-synuclein seed amplification assay amplification parameters and the risk of progression in prodromal parkinson disease. Neurology. https:\/\/doi.org\/10.1212\/WNL.0000000000210279","journal-title":"Neurology"},{"key":"2904_CR15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pcbi.1009480","author":"D Cresta","year":"2021","unstructured":"Cresta D, Warren DC, Quirouette C, Smith AP, Lane LC, Smith AM et al (2021) Time to revisit the endpoint dilution assay and to replace the TCID50 as a measure of a virus sample\u2019s infection concentration. PLoS Comput Biol. https:\/\/doi.org\/10.1371\/journal.pcbi.1009480","journal-title":"PLoS Comput Biol"},{"key":"2904_CR16","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-019-0333-5","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-019-0333-5","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2904_CR17","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/j.jalz.2017.09.014","volume":"14","author":"TJ Ferman","year":"2018","unstructured":"Ferman TJ, Aoki N, Crook JE, Murray ME, Graff-Radford NR, van Gerpen JA et al (2018) The limbic and neocortical contribution of \u03b1-synuclein, tau, and amyloid \u03b2 to disease duration in dementia with Lewy bodies. Alzheimers Dement 14(3):330\u2013339. https:\/\/doi.org\/10.1016\/j.jalz.2017.09.014","journal-title":"Alzheimers Dement"},{"key":"2904_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00401-024-02801-2","author":"T Freiburghaus","year":"2024","unstructured":"Freiburghaus T, Pawlik D, Hauer KO, Ossenkoppele R, Strandberg O, Leuzy A et al (2024) Association of in vivo retention of [18f] flortaucipir pet with tau neuropathology in corresponding brain regions. Acta Neuropathol. https:\/\/doi.org\/10.1007\/s00401-024-02801-2","journal-title":"Acta Neuropathol"},{"issue":"2","key":"2904_CR19","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1038\/ncb748","volume":"4","author":"H Fujiwara","year":"2002","unstructured":"Fujiwara H, Hasegawa M, Dohmae N, Kawashima A, Masliah E, Goldberg MS et al (2002) alpha-Synuclein is phosphorylated in synucleinopathy lesions. Nat Cell Biol 4(2):160\u2013164. https:\/\/doi.org\/10.1038\/ncb748","journal-title":"Nat Cell Biol"},{"key":"2904_CR20","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-022-00320-z","author":"MC Gonzalez","year":"2022","unstructured":"Gonzalez MC, Dalen I, Maple-Gr\u00f8dem TOB, Alves G (2022) Parkinson\u2019s disease clinical milestones and mortality. Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-022-00320-z","journal-title":"Parkinsons Dis"},{"key":"2904_CR21","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-018-0508-2","author":"BR Groveman","year":"2018","unstructured":"Groveman BR, Orr\u00f9 CD, Hughson AG, Raymond LD, Zanusso G, Ghetti B et al (2018) Rapid and ultra-sensitive quantitation of disease-associated \u03b1-synuclein seeds in brain and cerebrospinal fluid by \u03b1Syn RT-QuIC. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-018-0508-2","journal-title":"Acta Neuropathol Commun"},{"key":"2904_CR22","doi-asserted-by":"publisher","DOI":"10.1186\/s40478-022-01388-7","author":"S Hall","year":"2022","unstructured":"Hall S, Orr\u00f9 CD, Serrano GE, Galasko D, Hughson AG, Groveman BR et al (2022) Performance of \u03b1Synuclein RT-QuIC in relation to neuropathological staging of Lewy body disease. Acta Neuropathol Commun. https:\/\/doi.org\/10.1186\/s40478-022-01388-7","journal-title":"Acta Neuropathol Commun"},{"issue":"6","key":"2904_CR23","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1002\/mds.23669","volume":"26","author":"G Halliday","year":"2011","unstructured":"Halliday G, Lees A, Stern M (2011) Milestones in Parkinson\u2019s disease\u2013clinical and pathologic features. Mov Disord 26(6):1015\u20131021. https:\/\/doi.org\/10.1002\/mds.23669","journal-title":"Mov Disord"},{"issue":"10","key":"2904_CR24","doi-asserted-by":"publisher","first-page":"1313","DOI":"10.1016\/j.jalz.2018.05.008","volume":"14","author":"O Hansson","year":"2018","unstructured":"Hansson O, Mikulskis A, Fagan AM, Teunissen C, Zetterberg H, Vanderstichele H et al (2018) The impact of preanalytical variables on measuring cerebrospinal fluid biomarkers for Alzheimer\u2019s disease diagnosis: A review. Alzheimers Dement 14(10):1313\u20131333. https:\/\/doi.org\/10.1016\/j.jalz.2018.05.008","journal-title":"Alzheimers Dement"},{"issue":"2","key":"2904_CR25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/S1474-4422(23)00404-0","volume":"23","author":"GU H\u00f6glinger","year":"2024","unstructured":"H\u00f6glinger GU, Adler CH, Berg D, Klein C, Outeiro TF, Poewe W et al (2024) A biological classification of Parkinson\u2019s disease: the SynNeurGe research diagnostic criteria. Lancet Neurol 23(2):191\u2013204. https:\/\/doi.org\/10.1016\/S1474-4422(23)00404-0","journal-title":"Lancet Neurol"},{"issue":"4","key":"2904_CR26","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1002\/ana.23659","volume":"72","author":"DJ Irwin","year":"2012","unstructured":"Irwin DJ, White MT, Toledo JB, Zie SX, Robinson JL, Van Deerlin V et al (2012) Neuropathologic substrates of Parkinson disease dementia. Ann Neurol 72(4):587\u2013598. https:\/\/doi.org\/10.1002\/ana.23659","journal-title":"Ann Neurol"},{"issue":"5","key":"2904_CR27","doi-asserted-by":"publisher","first-page":"2029","DOI":"10.1093\/brain\/awad042","volume":"146","author":"CR Jack","year":"2023","unstructured":"Jack CR, Wiste HJ, Algeciras-Schimnich A, Figdore DJ, Schwarz CG, Lowe VJ et al (2023) Predicting amyloid PET and tau PET stages with plasma biomarkers. Brain 146(5):2029\u20132044. https:\/\/doi.org\/10.1093\/brain\/awad042","journal-title":"Brain"},{"issue":"Pt 6","key":"2904_CR28","doi-asserted-by":"publisher","first-page":"1755","DOI":"10.1093\/brain\/awq059","volume":"133","author":"PA Kempster","year":"2010","unstructured":"Kempster PA, O\u2019Sullivan SS, Holton JL, Revesz T, Lees AJ (2010) Relationships between age and late progression of Parkinson\u2019s disease: a clinico-pathological study. Brain 133(Pt 6):1755\u20131762. https:\/\/doi.org\/10.1093\/brain\/awq059","journal-title":"Brain"},{"key":"2904_CR29","doi-asserted-by":"publisher","DOI":"10.1186\/s13024-021-00501-z","author":"S Koga","year":"2021","unstructured":"Koga S, Sekiya H, Kondru N, Ross OA, Dickson DW (2021) Neuropathology and molecular diagnosis of Synucleinopathies. Mol Neurodegener. https:\/\/doi.org\/10.1186\/s13024-021-00501-z","journal-title":"Mol Neurodegener"},{"issue":"3","key":"2904_CR30","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.jalz.2019.09.079","volume":"16","author":"VJ Lowe","year":"2020","unstructured":"Lowe VJ, Lundt ES, Albertson SM, Min H-K, Fang P, Przybelski SA et al (2020) Tau-positron emission tomography correlates with neuropathology findings. Alzheimers Dement 16(3):561\u2013571. https:\/\/doi.org\/10.1016\/j.jalz.2019.09.079","journal-title":"Alzheimers Dement"},{"issue":"10","key":"2904_CR31","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1515\/cclm-2023-1472","volume":"62","author":"A Mammana","year":"2024","unstructured":"Mammana A, Baiardi S, Rossi M, Quadalti C, Ticca A, Magliocchetti F et al (2024) Improving protocols for \u03b1-synuclein seed amplification assays: analysis of preanalytical and analytical variables and identification of candidate parameters for seed quantification. Clin Chem Lab Med 62(10):2001\u20132010. https:\/\/doi.org\/10.1515\/cclm-2023-1472","journal-title":"Clin Chem Lab Med"},{"key":"2904_CR32","doi-asserted-by":"publisher","DOI":"10.1093\/brain\/awae405","author":"A Mastrangelo","year":"2025","unstructured":"Mastrangelo A, Mammana A, Hall S, Stomrud E, Zenesini C, Rossi M et al (2025) Alpha-synuclein seed amplification assay longitudinal outcomes in Lewy body disease spectrum. Brain 148(6)2038-2048.\u00a0https:\/\/doi.org\/10.1093\/brain\/awae405","journal-title":"Brain"},{"issue":"12","key":"2904_CR33","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1212\/01.wnl.0000187889.17253.b1","volume":"65","author":"IG McKeith","year":"2005","unstructured":"McKeith IG, Dickson DW, Lowe J, Emre M, O\u2019Brien JT, Feldman H et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the DLB Consortium. Neurology 65(12):1863\u20131872. https:\/\/doi.org\/10.1212\/01.wnl.0000187889.17253.b1","journal-title":"Neurology"},{"issue":"12","key":"2904_CR34","doi-asserted-by":"publisher","first-page":"3669","DOI":"10.1038\/s41591-024-03270-6","volume":"30","author":"G Pagano","year":"2024","unstructured":"Pagano G, Monnet A, Reyes A, Ribba B, Svoboda H, Kustermann T et al (2024) Sustained effect of prasinezumab on Parkinson\u2019s disease motor progression in the open-label extension of the PASADENA trial. Nat Med 30(12):3669\u20133675. https:\/\/doi.org\/10.1038\/s41591-024-03270-6","journal-title":"Nat Med"},{"issue":"1","key":"2904_CR35","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1002\/ana.20321","volume":"57","author":"L Parkkinen","year":"2005","unstructured":"Parkkinen L, Kauppinen T, Pirttil\u00e4 T, Autere JM, Alafuzoff I (2005) Alpha-synuclein pathology does not predict extrapyramidal symptoms or dementia. Ann Neurol 57(1):82\u201391","journal-title":"Ann Neurol"},{"key":"2904_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41531-021-00232-4","author":"C Quadalti","year":"2021","unstructured":"Quadalti C, Calandra-Buonaura G, Baiardi S, Mastrangelo A, Rossi M, Zenesini C et al (2021) Neurofilament light chain and \u03b1-synuclein RT-QuIC as differential diagnostic biomarkers in parkinsonisms and related syndromes. Parkinsons Dis. https:\/\/doi.org\/10.1038\/s41531-021-00232-4","journal-title":"Parkinsons Dis"},{"issue":"8","key":"2904_CR37","doi-asserted-by":"publisher","first-page":"1964","DOI":"10.1038\/s41591-023-02449-7","volume":"29","author":"C Quadalti","year":"2023","unstructured":"Quadalti C, Palmqvist S, Hall S, Rossi M, Mammana A, Janelidze S et al (2023) Clinical effects of Lewy body pathology in cognitively impaired individuals. Nat Med 29(8):1964\u20131970. https:\/\/doi.org\/10.1038\/s41591-023-02449-7","journal-title":"Nat Med"},{"issue":"1","key":"2904_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1007\/s00401-020-02160-8","volume":"140","author":"M Rossi","year":"2020","unstructured":"Rossi M, Candelise N, Baiardi S, Capellari S, Giannini G, Orr\u00f9 CD et al (2020) Ultrasensitive RT-QuIC assay with high sensitivity and specificity for Lewy body-associated synucleinopathies. Acta Neuropathol 140(1):49\u201362. https:\/\/doi.org\/10.1007\/s00401-020-02160-8","journal-title":"Acta Neuropathol"},{"issue":"5","key":"2904_CR39","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/S1474-4422(23)00109-6","volume":"22","author":"A Siderowf","year":"2023","unstructured":"Siderowf A, Concha-Marambio L, Lafontant D-E, Farris CM, Ma Y, Urenia PA et al (2023) Assessment of heterogeneity among participants in the Parkinson\u2019s Progression Markers Initiative cohort using \u03b1-synuclein seed amplification: a cross-sectional study. Lancet Neurol 22(5):407\u2013417. https:\/\/doi.org\/10.1016\/S1474-4422(23)00109-6","journal-title":"Lancet Neurol"},{"issue":"2","key":"2904_CR40","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.jneumeth.2010.06.017","volume":"191","author":"AH Simonsen","year":"2010","unstructured":"Simonsen AH, Bech S, Laursen I, Salvesen L, Winge K, Waldemar G et al (2010) Proteomic investigations of the ventriculo-lumbar gradient in human CSF. J Neuosci Methods 191(2):244\u2013248. https:\/\/doi.org\/10.1016\/j.jneumeth.2010.06.017","journal-title":"J Neuosci Methods"},{"issue":"2","key":"2904_CR41","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/S1474-4422(23)00405-2","volume":"23","author":"T Simuni","year":"2024","unstructured":"Simuni T, Chahine LM, Poston K, Brumm M, Buracchio T, Campbell M et al (2024) A biological definition of neuronal \u03b1-synuclein disease: towards an integrated staging system for research. Lancet Neurol 23(2):178\u2013190. https:\/\/doi.org\/10.1016\/S1474-4422(23)00405-2","journal-title":"Lancet Neurol"},{"issue":"11","key":"2904_CR42","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1136\/jnnp-2019-321111","volume":"90","author":"C Smith","year":"2019","unstructured":"Smith C, Malek N, Grosset K, Cullen B, Gentleman S, Grosset DG (2019) Neuropathology of dementia in patients with Parkinson\u2019s disease: a systematic review of autopsy studies. J Neurol Neurosurg Psychiatry 90(11):1234\u20131243. https:\/\/doi.org\/10.1136\/jnnp-2019-321111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"2904_CR43","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1012554","author":"A Srivastava","year":"2024","unstructured":"Srivastava A, Wang Q, Orr\u00f9 CD, Fernandez M, Compta Y, Ghetti B et al (2024) Enhanced quantitation of pathological \u03b1-synuclein in patient biospecimens by RT-QuIC seed amplification assays. PLoS Pathog. https:\/\/doi.org\/10.1371\/journal.ppat.1012554","journal-title":"PLoS Pathog"},{"key":"2904_CR44","doi-asserted-by":"publisher","first-page":"190","DOI":"10.1016\/j.expneurol.2012.11.020","volume":"240","author":"DG Walker","year":"2013","unstructured":"Walker DG, Lue L-F, Adler CH, Shill HA, Caviness JN, Sabbagh MN et al (2013) Changes in properties of serine 129 phosphorylated \u03b1-synuclein with progression of Lewy-type histopathology in human brains. Exp Neurol 240:190\u2013204. https:\/\/doi.org\/10.1016\/j.expneurol.2012.11.020","journal-title":"Exp Neurol"},{"issue":"4","key":"2904_CR45","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1093\/chemse\/bjq139","volume":"36","author":"RS Wilson","year":"2011","unstructured":"Wilson RS, Yu L, Schneider JA, Arnold SE, Buchman AS, Bennett DA et al (2011) Lewy bodies and olfactory dysfunction in old age. Chem Sens 36(4):367\u2013373. https:\/\/doi.org\/10.1093\/chemse\/bjq139","journal-title":"Chem Sens"}],"container-title":["Acta Neuropathologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00401-025-02904-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00401-025-02904-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T06:43:47Z","timestamp":1750661027000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00401-025-02904-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,23]]},"references-count":45,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,6]]}},"alternative-id":["2904"],"URL":"https:\/\/doi.org\/10.1007\/s00401-025-02904-4","relation":{},"ISSN":["1432-0533"],"issn-type":[{"value":"1432-0533","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,23]]},"assertion":[{"value":"27 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"OH is employed by Lund University and Eli Lilly.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}},{"value":"The operations of the Banner Sun Health Research Institute (SHRI) Brain and Body Donation Program have been approved by the WCG Institutional Review Board (IRB) of Puyallup, Washington, USA [\n                      \n                      ]. All enrolled subjects signed the IRB-approved informed consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}],"article-number":"67"}}